oxybutynin chloride

FDA Drug Profile — oxybutynin chloride, Oxybutynin Chloride

Drug Details

Generic Name
oxybutynin chloride
Brand Names
oxybutynin chloride, Oxybutynin Chloride
Application Number
ANDA207138
Sponsor
A-S Medication Solutions
NDC Codes
14
Dosage Forms
TABLET, EXTENDED RELEASE, TABLET
Routes
ORAL
Active Ingredients
OXYBUTYNIN CHLORIDE

Indications and Usage

INDICATIONS & USAGE Oxybutynin chloride tablets, USP are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).

Warnings

WARNINGS Angioedema of the face, lips, tongue and/or larynx has been reported with oxybutynin. In some cases, angioedema occurred after the first dose. Angioedema associated with upper airway swelling may be life-threatening. If involvement of the tongue, hypopharynx, or larynx occurs, oxybutynin should be promptly discontinued and appropriate therapy and/or measures necessary to ensure a patent airway should be promptly provided.